Do you want to read an article? Please log in or register.
Association of Retinal Architecture, Intrathecal Immunity, and Clinical Course in Multiple Sclerosis
Multiple Sclerosis
Related content
Multiple Sclerosis
Retinal Architecture and Melanopsin-Mediated Pupillary Response Characteristics: A Putative Pathophysiologic Signature for the Retino-Hypothalamic Tract in Multiple Sclerosis
JAMA Neurol.
Meltzer E, Sguigna PV, Subei A, Beh S, Kildebeck E, Conger D, Conger A, Lucero M, Frohman BS, Frohman AN, Saidha S, Galetta S, Calabresi PA, Rennaker R, Frohman TC, Kardon RH, Balcer LJ, Frohman EM
doi: 10.1001/
Multiple Sclerosis
Progressive multiple sclerosis is associated with faster and specific retinal layer atrophy
Ann Neurol.
Sotirchos ES, Caldito NG, Filippatou A, Fitzgerald KC, Murphy OC, Lambe J, Nguyen J, Button J, Ogbuokiri E, Crainiceanu CM, Prince JL, Calabresi PA, Saidha S, International Multiple Sclerosis Visual System (IMSVISUAL) Consortium.
doi: 10.1002/ana.25738.
SPECIAL REPORT
Multiple Sclerosis
Vaccination Readiness in Multiple Sclerosis
Multiple Sclerosis
Risk of natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: a retrospective analysis of data from four clinical studies
Lancet Neurol.
Ho PR, Koendgen H, Campbell N, Haddock B, Richman S, Chang I
doi: 10.1016/
SPECIAL REPORT
Multiple Sclerosis
Long-Term Real-World Use of Natalizumab Over 10 Years in Relapsing-Remitting Multiple Sclerosis
RECOMMENDED
Multiple Sclerosis
Serum neurofilament light chain level associations with clinical and cognitive performance in multiple sclerosis: A longitudinal retrospective 5-year study
★ 3
Recommended by
Prof. Dr Christian Kamm, Faculty Member
Mult Scler.
Jakimovski D, Zivadinov R, Ramanthan M, Hagemeier J, Weinstock-Guttman B, Tomic D, Kropshofer H, Fuchs TA, Barro C, Leppert D, Yaldizli Ö, Kuhle J, Benedict RH
doi: 10.1177/1352458519881428.
RECOMMENDED
Multiple Sclerosis
The apparently milder course of multiple sclerosis: changes in the diagnostic criteria, therapy and natural history
★ 1
Recommended by
Prof. Dr Claudio Gobbi, Faculty Member
Brain.
Sorensen PS, Sellebjerg F, Hartung HP, Montalban X, Comi G, Tintoré M
doi: 10.1093/brain/awaa145.
Multiple Sclerosis
Treatment with disease-modifying drugs for people with a first clinical attack suggestive of multiple sclerosis
Cochrane Database Syst Rev.
Filippini G, Del Giovane C, Clerico M, Beiki O, Mattoscio M, Piazza F, Fredrikson S, Tramacere I, Scalfari A, Salanti G
doi: 10.1002/
Multiple Sclerosis
Dimethyl fumarate influences innate and adaptive immunity in multiple sclerosis
J Autoimmun.
Diebold M, Sievers C, Bantug G, Sanderson N, Kappos L, Kuhle J, Lindberg RLP, Derfuss T
doi: 10.1016/j.jaut.2017.09.009.